EFTA01521059
EFTA01521060 DataSet-10
EFTA01521061

EFTA01521060.pdf

DataSet-10 1 page 169 words document
Open PDF directly ↗ View extracted text
👁 1 💬 0
📄 Extracted Text (169 words)
CHISLAINE MAXWELL ACCT. For the Period 2/1/12 to 2/29/12 Equity Summary Beginning Ending Change Current Asset Categories Asset Categories Market Value Market Value In Value Allocation US Large Cap Equity 112,244.53 11821284 2,968.31 1% US Small/Mid Cap Equity 5,940.00 6,000.00 60.00 1% Non-US Equity 374,029.22 395,528.88 21,499.66 5% Non-US Equity Preferred Stocks 429,082.00 436,402.00 7,320.00 5% Concentrated 8 Other Equity 202,541.50 205,872.00 3,330.50 2% U.S Stratilitid Cap Equity Unc'assfied 88.818.73 0.00 (88.818.73) unareedee Wei Total Value $1,210,653.98 $1,159,015.72 ($51,638.26) 14% EtOttattintit OMstrEisity Current Market Value/Cost Period Value Preteireci Stocks Market Value 1.159.015.72 Tax Cost 1.395.698.82 Unrealized Gain/Loss (233.945.61) Equity as a percentage of your portfok - 14 % Estimated Annual Income 46,969.28 Accrued Dividends 4,990.46 Yield 4.03% Note: ^ Unrealized Gain/Loss is shown as "N/A- in cases where we do not have appropriate cost information for all tax lots comprising the position. Please contact your J.P. Morgan team for additional information. Equity Detail J.P. Morgan Page 4 of 33 Confidential Treatment Requested by JPMorgan JPM-SDNY-00048417 Chase CONFIDENTIAL SDNY_GM_00317615 EFTA01521060
ℹ️ Document Details
SHA-256
33574e70e15c7343f997de47eaa2dbe5bbc1c762e35bc49a32b264d5333b6e20
Bates Number
EFTA01521060
Dataset
DataSet-10
Document Type
document
Pages
1

Comments 0

Loading comments…
Link copied!